Other languages Biofrontera AG

Equities

B8F

DE0006046113

Delayed Xetra Other stock markets 11:36:05 2024-05-06 am EDT			5-day change	1st Jan Change
0.35 ^EUR	0.00%		0.00%	-12.72%

Apr. 30	Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 11	Biofrontera Files Prospectus for Potential Secondary Stock Offerings	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30
Biofrontera : Jahresfinanzbericht 2023 nach HGB	Apr. 30
Biofrontera : Abstimmungsergebnisse	Apr. 03
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	Mar. 11
MORNING BRIEFING - Deutschland/Europa -2-	Feb. 16
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28
Biofrontera Licensor Gets FDA Approval for New Formulation of Ameluz to Treat Actinic Keratosis	23-10-10
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31
Biofrontera Says Skin Disease Therapy Was Well-Tolerated in Phase 1 Safety Trial	23-08-28
Biofrontera Completes Patient Enrollment in Skin Cancer Treatment Study	23-08-10
Top Premarket Decliners	23-07-21
Biofrontera Launches Novel Belixos Active Care	23-07-05
Biofrontera to Effect 1-for-20 Reverse Stock Split	23-07-03
Wall Street Set to Open Lower; Housing Starts Rise More Than Expected	23-06-20
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31
Biofrontera AG Completes Patient Recruitment of Ameluz Phase I Trial	23-05-17
Biofrontera Says it Obtained US Patent for New Photodynamic Therapy Protocol	23-05-15
Biofrontera Enters $6.5 Million Line of Credit With MidCap Business Credit	23-05-11
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28
Biofrontera Reports Completion of Last Patient Visit in Phase 1 Study to Treat Actinic Keratosis	23-04-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biofrontera AG

Equities

B8F

DE0006046113

Other languages

Filters